Argenx Se earnings were $1.9B for the trailing 12 months ending Jun 30, 2026, with 26% growth year over year. The latest ARGX earnings report on Jun 30, 2026 announced Q2 2026 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ARGX reported annual earnings of $1.5B, with 75.2% growth.
ARGX past earnings growth
How has ARGX's earnings growth performed historically?
On ARGX's earnings call on Jul 23, 2026, Argenx Se (NASDAQ: ARGX) reported Q2 2026 earnings per share (EPS) of N/A, up N/A year over year. Total ARGX earnings for the quarter were N/A. In the same quarter last year, Argenx Se's earnings per share (EPS) was N/A.
As of the last Argenx Se earnings report, Argenx Se is currently profitable. Argenx Se's net profit (also called net income) for the twelve months ending Jun 30, 2026 was $1.95 billion, a 29.37% increase year over year.
What was ARGX's earnings growth in the past year?
As of Argenx Se's earnings date in Jul 23, 2026, Argenx Se's earnings has grown 26.02% year over year. This is 4.51 percentage points higher than the US Biotechnology industry earnings growth rate of 21.51%. ARGX earnings in the past year totalled $1.95 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.